全文获取类型
收费全文 | 335篇 |
免费 | 18篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 20篇 |
妇产科学 | 16篇 |
基础医学 | 65篇 |
口腔科学 | 9篇 |
临床医学 | 37篇 |
内科学 | 58篇 |
皮肤病学 | 23篇 |
神经病学 | 31篇 |
特种医学 | 4篇 |
外科学 | 24篇 |
预防医学 | 26篇 |
眼科学 | 2篇 |
药学 | 19篇 |
肿瘤学 | 15篇 |
出版年
2022年 | 2篇 |
2020年 | 5篇 |
2019年 | 8篇 |
2018年 | 3篇 |
2017年 | 10篇 |
2016年 | 7篇 |
2015年 | 7篇 |
2014年 | 16篇 |
2013年 | 21篇 |
2012年 | 24篇 |
2011年 | 33篇 |
2010年 | 11篇 |
2009年 | 2篇 |
2008年 | 16篇 |
2007年 | 19篇 |
2006年 | 18篇 |
2005年 | 16篇 |
2004年 | 13篇 |
2003年 | 21篇 |
2002年 | 13篇 |
2000年 | 3篇 |
1999年 | 8篇 |
1998年 | 6篇 |
1997年 | 6篇 |
1996年 | 6篇 |
1995年 | 5篇 |
1994年 | 4篇 |
1993年 | 3篇 |
1992年 | 2篇 |
1984年 | 2篇 |
1982年 | 2篇 |
1980年 | 4篇 |
1978年 | 3篇 |
1976年 | 2篇 |
1974年 | 2篇 |
1966年 | 1篇 |
1965年 | 1篇 |
1937年 | 1篇 |
1936年 | 1篇 |
1934年 | 2篇 |
1932年 | 1篇 |
1931年 | 1篇 |
1930年 | 1篇 |
1929年 | 1篇 |
1928年 | 1篇 |
1927年 | 1篇 |
1923年 | 1篇 |
1922年 | 1篇 |
1916年 | 1篇 |
1914年 | 1篇 |
排序方式: 共有353条查询结果,搜索用时 15 毫秒
21.
22.
Grete S. Pedersen Janneke G. F. Hogervorst Leo J. Schouten Erik J. M. Konings R. Alexandra Goldbohm Piet A. van den Brandt 《Breast cancer research and treatment》2010,122(1):199-210
Acrylamide, a potential human carcinogen, has been discovered in a variety of heat-treated carbohydrate-rich food products.
Previously, dietary acrylamide intake was shown to be associated with endocrine-related cancers in humans. We assessed the
association between dietary acrylamide intake and risk of postmenopausal breast cancer stratified by estrogen and progesterone
receptor status. This study was embedded within the Netherlands Cohort Study on diet and cancer, which was initiated in 1986
enrolling 62,573 women aged 55–69 years at baseline. After 13.3 years of follow-up, 2225 incident breast cancer cases were
ascertained, with hormone receptor status information for 43%. Cox proportional hazards analysis was applied to determine
hazard ratios in quintiles of dietary acrylamide intake stratifying on estrogen receptor (ER) and progesterone receptor (PR)
and smoking status. No association was observed for overall breast cancer or receptor-negative breast cancer risk, irrespective
of smoking status. A statistically non-significantly increased risk of ER positive, PR positive and joint receptor-positive
breast cancer was found in never-smoking women. The multivariable-adjusted hazard ratios were 1.31 (95% CI: 0.87–1.97, P
trend = 0.26) for ER+, 1.47 (0.86–2.51, P
trend = 0.14) for PR+, and 1.43 (0.83–2.46, P
trend = 0.16) for ER+PR+, when comparing women in the highest quintile of acrylamide intake (median 36.8 μg/day) to women in the
lowest (median 9.5 μg/day). This study showed some indications of a positive association between dietary acrylamide intake
and receptor-positive breast cancer risk in postmenopausal never-smoking women. Further studies are needed to confirm or refute
our observations. 相似文献
23.
Lim J Goriely A Turner GD Ewen KA Jacobsen GK Graem N Wilkie AO Rajpert-De Meyts E 《The Journal of pathology》2011,224(4):473-483
Spermatocytic seminoma (SS) is a rare testicular neoplasm that occurs predominantly in older men. In this study, we aimed to shed light on the histogenesis of SS by investigating the developmental expression of protein markers that identify distinct subpopulations of human spermatogonia in the normal adult testis. We analysed the expression pattern of OCT2, SSX2-4, and SAGE1 in 36 SS cases and four intratubular SS (ISS) as well as a series of normal testis samples throughout development. We describe for the first time two different types of SS characterized by OCT2 or SSX2-4 immunoexpression. These findings are consistent with the mutually exclusive antigenic profile of these markers during different stages of testicular development and in the normal adult testis. OCT2 was expressed predominantly in A(dark) spermatogonia, SSX2-4 was present in A(pale) and B spermatogonia and leptotene spermatocytes, whilst SAGE1 was exclusively present in a subset of post-pubertal germ cells, most likely B spermatogonia. The presence of OCT2 and SSX2-4 in distinct subsets of germ cells implies that these markers represent germ cells at different maturation stages. Analysis of SAGE1 and SSX2-4 in ISS showed spatial differences suggesting ongoing maturation of germ cells during progression of SS tumourigenesis. We conclude that the expression pattern of OCT2, SSX2-4, and SAGE1 supports the origin of SS from spermatogonia and provides new evidence for heterogeneity of this tumour, potentially linked either to the cellular origin of SS or to partial differentiation during tumour progression, including a hitherto unknown OCT2-positive variant of the tumour likely derived from A(dark) spermatogonia. 相似文献
24.
Thermal dosimetry predictive of efficacy of 111In-ChL6 nanoparticle AMF--induced thermoablative therapy for human breast cancer in mice. 总被引:3,自引:0,他引:3
Sally J DeNardo Gerald L DeNardo Arutselvan Natarajan Laird A Miers Allan R Foreman Cordula Gruettner Grete N Adamson Robert Ivkov 《Journal of nuclear medicine》2007,48(3):437-444
Antibody (mAb)-linked iron oxide nanoparticles (bioprobes) provide the opportunity to develop tumor specific thermal therapy (Rx) for metastatic cancer when inductively heated by an externally applied alternating magnetic field (AMF). To evaluate the potential of this Rx, in vivo tumor targeting, efficacy, and predictive radionuclide-based heat dosimetry were studied using (111)In-ChL6 bioprobes (ChL6 is chimeric L6) in a human breast cancer xenograft model. METHODS: Using carbodiimide, (111)In-DOTA-ChL6 (DOTA is dodecanetetraacetic acid) was conjugated to polyethylene glycol-iron oxide-impregnated dextran 20-nm particles and purified as (111)In-bioprobes. (111)In doses of 740-1,110 kBq (20-30 muCi) (2.2 mg of bioprobes) were injected intravenously into mice bearing HBT3477 human breast cancer xenografts. Pharmacokinetic (PK) data were obtained at 1, 2, 3, and 5 d. AMF was delivered 72 h after bioprobe injection at amplitudes of 1,410 (113 kA/m), 1,300 (104 kA/m), and 700 (56 kA/m) oersteds (Oe) at 30%, 60%, and 90% "on" time (duty), respectively, and at 1,050 Oe (84 kA/m) at 50% and 70% duty over the 20-min treatment. Treated and control mice were monitored for 90 d. Tumor total heat dose (THD) from activated tumor bioprobes was calculated for each Rx group using (111)In-bioprobe tumor concentration and premeasured particle heat response to AMF amplitudes. Tumor growth delay was analyzed by Wilcoxon rank sum comparison of time to double, triple, and quintuple tumor volume in each group, and all groups were compared with the controls. RESULTS: Mean tumor concentration of (111)In-bioprobes at 48 h was 14 +/- 2 percentage injected dose per gram; this concentration 24 h before AMF treatment was used to calculate THD. No particle-related toxicity was observed. Toxicity was observed at the highest AMF amplitude-duty combination of 1,300 Oe and 60% over 20 min; 6 of 10 mice died acutely. Tumor growth delay occurred in all of the other groups, correlated with heat dose and, except for the lowest heat dose group, was statistically significant when compared with the untreated group. Electron microscopy showed (111)In-bioprobes on tumor cells and cell death by necrosis at 24 and 48 h after AMF. CONCLUSION: mAb-guided bioprobes (iron oxide nanoparticles) effectively targeted human breast cancer xenografts in mice. THD, calculated using empirically observed (111)In-bioprobe tumor concentration and in vitro nanoparticle heat induction by AMF, correlated with tumor growth delay. 相似文献
25.
The effects of 3 weeks' or 6 months' inhalation exposure of rats to aromatic white spirit 6 h/day, 5 days/week at 0, 400, or 800 ppm were studied. Synaptosomal neurochemistry was investigated as index of the in situ conditions in the presynaptic nerve terminal. In both studies, the relative and absolute yield of synaptosomal protein were significantly reduced in the two exposed groups. Both studies demonstrated increased synaptosomal noradrenaline (NA), dopamine (DA), and 5-hydroxytryptamine (5-HT) concentrations, high-affinity 5-HT uptake rate and uptake capacity. It is hypothesized that a reduced density and total number of synapses in situ may be functionally compensated by increased NA, DA, and 5-HT neurotransmitter release, or by increased activity of corresponding neurons. The increased synaptosomal 5-HT uptake rates and uptake capacities may explain the previously demonstrated increased global and regional neurotransmitter concentrations and the present finding of increased synaptosomal 5-HT concentrations. These changes are interpreted as an indication of toxic effect on the CNS function and are considered supportive of recent findings of electrophysiological changes and affected motor activity following 6 months' exposure to dearomatized white spirit followed by an exposure-free period. 相似文献
26.
Veldman C Eming R Wolff-Franke S Sonderstrup G Kwok WW Hertl M 《Clinical immunology (Orlando, Fla.)》2007,122(3):330-337
In the present study, we developed a HLA class II tetramer-based detection system utilizing DRB1*0402 tetramers loaded with recently identified immunodominant peptides of desmoglein 3 (Dsg3), the major autoantigen of pemphigus vulgaris (PV). Initial experiments demonstrated staining of a Dsg3-reactive T cell hybridoma which was derived from HLA-DR0402-transgenic mice with loaded PE-labeled DRbeta1*0402 tetramers. However, staining of autoreactive T cell clones (TCC) derived from PV patients resulted only in positive staining by addition of exogenous peptides to the staining reactions. There was a dose-dependent specific binding of TCC to the tetramers with the agonistic Dsg3 peptide which was not altered by exogenous unrelated Dsg3 peptide. Noteworthy, the TCC did not stain with HLA-DR4 tetramers complexed with unrelated Dsg3 peptides. The findings of this study suggest that HLA class II tetramers may provide a highly specific approach to monitor ex vivo the T cellular autoimmune response against Dsg3 in patients with PV. 相似文献
27.
28.
29.
Anne‐Grete Mrtson Anette Veringa Edwin R. van den Heuvel Martijn Bakker Daan J. Touw Tjip S. van der Werf Lambert F. R. Span Jan‐Willem C. Alffenaar 《Mycoses》2019,62(8):698-705
Posaconazole is indicated for prophylaxis and treatment of invasive aspergillosis. Therapeutic drug monitoring (TDM) of posaconazole is used to optimise drug exposure. The aim of this study was to analyse and describe the TDM practices and exposure of posaconazole tablets. Patients who received posaconazole for treatment or prophylaxis of fungal infections were included in the study. The following therapeutic window was defined: if concentration was low (<0.7 mg/L for prophylaxis or < 1.5 mg/L for treatment) or high (>3.75 mg/L), the hospital pharmacist provided the physician with dosage advice, which implementation to patient care was analysed. A longitudinal analysis was performed to analyse if different confounding variables had an effect on posaconazole concentrations. Forty‐seven patients were enrolled resulting in 217 posaconazole trough concentrations. A median of 3 (IQR 1‐7) samples was measured per patient. The median concentration was 1.7 mg/L (IQR 0.8‐2.7) for prophylaxis and 1.76 mg/L (IQR 1.3‐2.3) for treatment. Overall, 78 posaconazole concentrations were out of the therapeutic window. For 45 (54%) of these concentrations, a dosage change was recommended. In the longitudinal analysis, the laboratory markers and patient baseline variables did not have an effect on posaconazole concentrations. Adequate posaconazole exposure was shown in 64% (affected 28 patients) of the measured concentrations. TDM practice of posaconazole can be improved by increasing the implementation rate of dose recommendation by a multidisciplinary antifungal stewardship team. 相似文献
30.
Dr. Grete Herrenschneider-Gumprich Dr. Karl Herrenschneider 《Journal of neurology》1916,54(5):289-302
Ohne ZusammenfassungProfessor Dr. Sänger gewidmet aus Anlass seiner 25jährigen Tätigkeit im Krankenhause St. Georg. 相似文献